ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1063

Longitudinal Measures of Short Physical Performance Battery and Risk for CKD Progression and Death

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Schrauben, Sarah J., University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Nair, Devika, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Brown, Rebecca T., University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Shlipak, Michael, San Francisco VA Health Care System, San Francisco, California, United States
  • Tangri, Navdeep, University of Manitoba, Winnipeg, Manitoba, Canada
  • Hannan, Mary F., University of Illinois Chicago, Chicago, Illinois, United States
  • Lash, James P., University of Illinois Chicago, Chicago, Illinois, United States
  • Navaneethan, Sankar D., Baylor College of Medicine, Houston, Texas, United States
  • Leonard, Mary B., Stanford University School of Medicine, Stanford, California, United States
  • Chen, Jing, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • He, Jiang, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Appel, Lawrence J., Johns Hopkins Medicine, Baltimore, Maryland, United States
  • Rincon-Choles, Hernan, Cleveland Clinic, Cleveland, Ohio, United States
  • Kansal, Mayank, University of Illinois Chicago, Chicago, Illinois, United States
  • Yang, Wei, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
Background

We aimed to characterize physical performance using the Short Physical Performance Battery (SPPB) and test whether physical performance is associated with incident kidney failure and death in a cohort of adults with chronic kidney disease (CKD).

Methods

Using data from the Chronic Renal Insufficiency Cohort (CRIC) Study, we calculated SPPB scores from three performance measures (standing balance, gait speed, chair stands). SPPB scores were categorized into peformance levels using validated cut-offs: low (0-6), moderate (7-9), and high (10-12). We estimated the associations of baseline SPPB and longidutinal SPPB change, modelled continuously and by performance category, with incident kidney failure and death using multivariable Cox models.

Results

Among 3,038 participants, mean age was 64 years, 40% were Black, 52% had diabetes and mean eGFR was 52 ml/min/1.73m^2. Median (IQR) follow up was 8.5 years (7-10). The baseline median (IQR) SPPB score was 10 (8-11), indicating median high performance. In fully adjusted models, lower baseline SPPB scores (per 1-unit) and low and moderate performance categories were associated with increased risk of death (Table). As a linear measure, SPPB declines were associated with higher risk of death; and a >2 point decline was associated with 78% higher mortality risk compared to no change (Table). Baseline and SPPB change were not associated with incident kidney failure.

Conclusion

Baseline physical peformance and its changes over time, as measured by the SPPB, are independently associated with death. The SPPB may be a useful tool for risk assessment in this population.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)